Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
01/2011
01/04/2011US7863449 Modulators of muscarinic receptors
01/04/2011US7863310 Kinase inhibitors
01/04/2011US7863293 Aminoalkylpyridines; treating HIV infections; antiinflammatory agents; rheumatic diseases; elevating progesator and stem cell count
01/04/2011US7863290 drugs such as 5-(6-Chloropyridazin-3-yl)-1-azabicyclo[3.2.1]octane, used for treatment or prevention of disorders related to a nicotinic receptor dysfunction
01/04/2011US7863288 protein kinase modulators such as Propane-1-sulfonic acid [2,4-difluoro-3-(5-ethoxy-1H-pyrrolo[1,3-b]pyridine-3-carbonyl)-phenyl]-amide, used to regulate signal transduction cascades, involved in the control of physiological functions including cellular growth and proliferation; anticarcinogenic agents
01/04/2011US7863281 4-[(3-chloro-4-fluoro-phenyl)amino]-6-{[4-((1S,4S)-2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl)-1-oxo-2-buten-1-yl]amino}-7-cyclopropylmethoxy-quinazoline; inhibitor of signal transduction mediated by tyrosine kinases; antitumor agent; benign prostatic hyperplasia, lungs and respiratory tract disease; bile duct
01/04/2011US7863279 monoacyl glycerol lipase and fatty acid amide hydrolase inhibitors such as [5-(2-chlorophenyl)[1,2,3]triazolo[4,5-b]pyridin-3-yl][4-(3-trifluoromethylphenyl) piperazin-1-yl]methanone, used as analgesics or for the treatment of vomiting and nausea
01/04/2011US7863278 Isethionate salt of a selective CDK4 inhibitor
01/04/2011US7863269 Imino-imidazo-pyridine derivatives having antithrombotic activity
01/04/2011US7863266 Therapeutic pyrazoloquinoline urea derivatives
01/04/2011CA2505555C Spirocyclic cyclohexane derivatives
01/04/2011CA2468517C Thioether substituted imidazoquinolines
01/04/2011CA2458533C Imidazole derivates as anti-inflammatory agents
01/04/2011CA2429312C Novel pyridine-substituted pyrazolopyridine derivatives
12/2010
12/30/2010US20100331543 Cyanine dyes and their applications as luminescence quenching compounds
12/30/2010US20100331525 Antitumoral agents with a benzophenanthridine structure and formulations containing them
12/30/2010US20100331359 Novel compound useful for the treatment of degenerative and inflammatory diseases
12/30/2010US20100331358 Tetrahydrofuropyridones
12/30/2010US20100331355 Substituted Quinolines for the Treatment of Cancer
12/30/2010US20100331353 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof
12/30/2010US20100331339 (1-azinone)-substituted pyridoindoles
12/30/2010US20100331335 Inhibitors of Jun N-Terminal Kinase
12/30/2010US20100331323 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives
12/30/2010US20100331318 Azatricyclic antibiotic compounds
12/30/2010US20100331308 Oxazolidinone derivatives
12/30/2010US20100331306 Heterocyclic compounds and their uses
12/30/2010US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
12/30/2010US20100331296 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
12/30/2010US20100331294 4-substituted-2-amino-pyrimidine derivatives
12/30/2010US20100331283 Mitotic kinesin inhibitors and methods of use thereof
12/30/2010US20100330165 Use of chemotherapeutic agents
12/30/2010US20100330030 Vasculostatic Agents and Methods of Use Thereof
12/29/2010WO2010151815A2 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof
12/29/2010WO2010151791A1 Heterocyclic compounds and their uses
12/29/2010WO2010151735A2 Heterocyclic compounds and their uses
12/29/2010WO2010151006A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/29/2010WO2010150281A2 Novel azabicyclohexanes
12/29/2010WO2010149944A1 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer
12/29/2010WO2010149943A1 New compounds and medical use
12/29/2010WO2010149786A1 Pyrido [2, 3-d] pyrimidines as wnt antagonists for treatment of cancer and arthritis
12/29/2010WO2010149783A1 Tricyclic pyrimidine derivatives as wnt antagonists
12/29/2010WO2010149771A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
12/29/2010WO2010149769A1 5-phenyl-[1,2,4 ]triazolo[1,5-a]pyridin-2-yl carboxamides as jak inhibitors
12/29/2010WO2010149685A1 New compounds, pharmaceutical composition and methods relating thereto
12/29/2010WO2010129848A3 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamides
12/29/2010EP2266985A1 Tricyclic Pyrimidine Derivatives as Wnt antagonists
12/29/2010EP2266984A1 Pyrido[2,3-d]pyrimidines as Wnt antagonists for treatment of cancer and arthritis
12/29/2010EP2266983A1 Nitrogenated 5-membered heterocyclic compound
12/29/2010EP2266971A2 Hiv protease inhibiting compounds
12/29/2010EP2266962A1 The compounds as the estrogen related receptors modulators and the uses thereof
12/29/2010EP2266150A1 N-type semiconductor materials in thin film transistors
12/29/2010EP2265611A1 Tricyclic derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/29/2010EP2265610A1 Pyrazole [3, 4-b]pyridine raf inhibitors
12/29/2010EP2265609A1 Imdizo [4. 5-b] pyridine derivatives used as raf inhibitors
12/29/2010EP2265608A2 Raf inhibitor compounds and methods of use thereof
12/29/2010EP2265598A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
12/29/2010EP2265588A1 INHIBITORS OF 11ß -HYDROXYSTEROID DEHYDROGENASE TYPE 1
12/29/2010EP2265335A1 Indazole derivatives
12/29/2010EP2265270A1 2-aminopyridine kinase inhibitors
12/29/2010EP2265120A1 Herbicidal coumpounds
12/29/2010EP2265118A2 Fungicide hydroximoyl-tetrazole derivatives
12/29/2010EP2069341B1 Pyrrolo[2, 3-b]pyridin-4-yl-benzenesulfonamide compounds as ikk2 inhibitors
12/29/2010EP2022792B1 Novel compound having affinity to amyloid
12/29/2010EP1999129B1 Compounds and methods for inhibiting hepatitis c viral replication
12/29/2010EP1951251B1 Spirohydantoin aryl cgrp receptor antagonists
12/29/2010EP1861377B1 Benzimidazolone derivatives as cb2 receptor ligands
12/29/2010EP1713810B1 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
12/29/2010EP1560827B1 Anti-infective agents
12/29/2010CN1926132B Pyrazole compounds useful as protein kinase inhibitors
12/29/2010CN101932581A Compound having substituted pyridyl group and pyridoindole ring structure linked through phenylene group, and organic electroluminescent device
12/29/2010CN101932580A Imidazopyridine kinase inhibitors
12/29/2010CN101932579A New imidazolo-heteroaryl derivatives with antibacterial properties
12/29/2010CN101928287A Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
12/29/2010CN101208339B Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents
12/29/2010CN101208338B Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents
12/29/2010CN101166740B Imidazo (1,2-a) pyridine derivatives useful as peptide deformylase (PDF) inhibitors
12/29/2010CN101103029B 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-infective agents
12/29/2010CN101052400B Application of pyridine compound for preparing medicine for curing injured skin
12/29/2010CA2803330A1 Indolyl-substituted pyrazino-quinolines and their use for the treatment of cancer
12/29/2010CA2781865A1 Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
12/29/2010CA2766033A1 Prodrugs of nh-acidic compounds
12/29/2010CA2765988A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
12/29/2010CA2765985A1 5-phenyl-[1,2,4 ]triazolo[1,5-a]pyridin-2-yl carboxamides as jak inhibitors
12/29/2010CA2765823A1 Tricyclic heterocyclic compounds as mediators of p13k activity
12/29/2010CA2765819A1 Heterocyclic compounds and their uses as inhibitors of p13 k activity
12/29/2010CA2765817A1 Heterocyclic compounds and their uses
12/29/2010CA2765692A1 Novel azabicyclohexanes
12/28/2010US7858809 N-cyclopropylmethyl-N-(2-ethyl-7-iodopyrazolo[1,5-a]pyridine-3-yl)-N-(tetrahydro-2H-4 -pyranylmethyl)amine hydrochloride; for prevention or treatment of depression, anxiety and the like as a corticotrophin-releasing-factor (CRF) receptor antagonist
12/28/2010US7858790 1'-(Bicyclo[2.2.1]heptan-2-yl)-N-methylspiro[indene-1,4'-piperidine]-3-carboxamide; 1'-(3,3- dimethylbutyl)spiro[indene-1,4'-piperidine]-3-carboxylic acid; modulators of muscarinic receptors M1-M5; subtype-selective antagonists; analgesics; psychoses; Alzeimer's disease; Parkinson's disease; asthma
12/28/2010US7858788 e.g. 9-Hydroxy-2-(2-methoxy-ethyl)-1,8-dioxo-1,8-dihydro-2H-pyrid[1,2-a]pyrazi ne-7-carboxylic acid 4-fluoro-banzylamide; Human T cell leukemia virus, Feline and Simian immunodeficiency virus inhibitor; side effects reduction
12/28/2010US7858641 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes
12/28/2010US7858639 [1,2,4]triazolo[4,3-a]pyridazine derivatives such as 6-(2-chlorophenyl)-7-(4-chlorophenyl)-3-[[2-methyl-6-(trifluoromethyl)pyridin-3-yl]methyl]-[1,2,4]triazolo[4,3-a]pyridine, used for the treatment of obesity and hyperlipemia, or as antidiabetic, antilipemic, anticholesterol and hypotensive agents
12/28/2010US7858631 such as (3R,5S)-N-(3-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-7-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used as melanocortin-4 receptor (MC4-R) agonists, for the treatment of obesity or diabetes
12/28/2010US7858614 Therapeutic pyrazolonaphthyridine derivatives
12/23/2010WO2010147975A1 Gamma secretase modulators
12/23/2010WO2010147973A1 Gamma secretase modulators
12/23/2010WO2010147133A1 Novel imidazopyridine compound
12/23/2010WO2010147094A1 Compound having spiro-bonded cyclic group and use thereof
12/23/2010WO2010147068A1 Substituted polycyclic carbamoylpyridone derivative
12/23/2010WO2010146594A1 Novel polymorphs of gemifloxacin mesylate
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 646